Author

E. B. Wilson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. A. Melcher· 2 shared G. P. Cook· 2 shared A. Droop· 1 shared A. P. Droop· 1 shared H. J. Close· 1 shared H. Wurdak· 1 shared J. A. Newton-Bishop· 1 shared J. Nsengimana· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. A. Melcher

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Oncolytic virus treatment differentially affects the CD56dim and CD56bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity

M. Wantoch, E. B. Wilson, A. P. Droop, S. L. Phillips, M. Coffey, Y. M. El-Sherbiny, T. D. Holmes, A. A. Melcher, L. F. Wetherill, G. P. Cook

This study shows reovirus treatment affects CD56dim and CD56bright NK cell subsets differently, modulating their activity and signaling pathways in vivo.

bioRxiv · Dec 16, 2020 · PreprintImmunology

Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered natural killer cell phenotype in glioblastoma

H. J. Close, L. F. Stead, J. Nsengimana, K. Reilly, A. Droop, H. Wurdak, R. K. Mathew, R. Corns, J. A. Newton-Bishop, A. A. Melcher, S. C. Short, G. P. Cook, E. B. Wilson

bioRxiv · Oct 4, 2019Immunology